Stay updated on SKI-G-801 Dose Study in AML Clinical Trial
Sign up to get notified when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.

Latest updates to the SKI-G-801 Dose Study in AML Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedIntroducing version v3.2.0 and a government-operating-status notice; removing the older v3.1.0 reference.SummaryDifference4%
- Check20 days agoChange DetectedUpgrade applied: version updated from v3.0.2 to v3.1.0. No other substantive content changes detected.SummaryDifference0.1%
- Check27 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows Revision: v3.0.2 (replacing v3.0.1); a minor UI element, 'Back to Top', was removed.SummaryDifference0.2%
- Check42 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check49 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while several specific medical conditions related to leukemia have been removed. The revision number has also been updated.SummaryDifference3%
- Check56 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.9%
Stay in the know with updates to SKI-G-801 Dose Study in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SKI-G-801 Dose Study in AML Clinical Trial page.